Presumed Silicone Oil Droplets After Intravitreal Pegcetacoplan Injections.

ABSTRACT:

Importance

Recently, intravitreal pegcetacoplan became the first drug to gain US Food and Drug Administration approval for the treatment of geographic atrophy associated with nonexudative age-related macular degeneration, but the administration of this medication may be associated with unanticipated posttreatment complications.

Objective

To assess the prevalence of presumed silicone oil droplets in the vitreous cavity after intravitreal injection of pegcetacoplan.

Design, setting, and participants

This case series study involved a retrospective record review of all 55 patients treated with intravitreal pegcetacoplan, 0.1 mL in 150-mg/mL solution, between March 24 and June 5, 2023, at a single specialty retina practice. All injections were done using needles from the k

SUBMITTER: Dessouki A 

PROVIDER: S-EPMC10557030 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature